Status:

RECRUITING

FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach

Lead Sponsor:

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Conditions:

Clostridium Difficile

Ulcerative Colitis

Eligibility:

All Genders

18-75 years

Phase:

PHASE1

PHASE2

Brief Summary

Clostridioides difficile infection (CDI) is the most frequent cause of infectious diarrhea in hospitalized patients and is responsible for 20-30 % of antibiotic-associated diarrhea cases. Inflammatory...

Detailed Description

Clostridioides difficile infection (CDI) is the most frequent cause of infectious diarrhea in hospitalized patients and is responsible for 20-30 % of antibiotic-associated diarrhea cases. Inflammatory...

Eligibility Criteria

Inclusion

  • Age ≥18 years;
  • Active UC (partial Mayo score ≥2);
  • Relapsing infection of C. difficile;
  • Ability to express consent for inclusion in the study.
  • Indication, in the clinical practice setting, for fecal microbiota transplantation from a healthy donor for recurrent CDI

Exclusion

  • Age \< 18 years;
  • Other gastrointestinal infections, excluding C. difficile;
  • Known gastrointestinal diseases, other than UC, in active stage (e.g., infectious gastroenteritis, celiac disease, irritable bowel syndrome, chronic pancreatitis, bile acid diarrhea, etc.);
  • Previous colon surgery or skin ostomy packing;
  • Food allergies;
  • Current or recent (\<2 weeks) therapy with drugs that may alter the microbiota (e.g., systemic antimicrobials, probiotics, proton pump inhibitors, immunosuppressants, metformin), except antibiotics against C. difficile;
  • Heart failure or heart disease with FE ≤ 30 %;
  • Severe respiratory failure;
  • Psychiatric disorders;
  • Pregnancy and lactation;
  • Inability to provide informed consent.

Key Trial Info

Start Date :

September 23 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 24 2025

Estimated Enrollment :

64 Patients enrolled

Trial Details

Trial ID

NCT06071312

Start Date

September 23 2023

End Date

September 24 2025

Last Update

March 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Digestive Disease Center, Fondazione Policlinico Univesitario A. Gemelli IRCCS

Rome, Italy, 00168